These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 16060994)

  • 1. [Enhancing effects of celecoxib on the growth inhibition of pancreatic carcinoma by gemcitabine treatment].
    Xu G; Wu K; Wang XP; Zhao S
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):986-91. PubMed ID: 16060994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gemcitabine/Irinotecan/celecoxib in pancreatic cancer.
    Lipton A; Harvey H; Witters L; Kerr S; Legore K; Campbell C
    Oncology (Williston Park); 2004 Dec; 18(14 Suppl 14):43-5. PubMed ID: 15685834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase-2-dependent and -independent effects of celecoxib in pancreatic cancer cell lines.
    El-Rayes BF; Ali S; Sarkar FH; Philip PA
    Mol Cancer Ther; 2004 Nov; 3(11):1421-6. PubMed ID: 15542781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II study of celecoxib, gemcitabine, and cisplatin in advanced pancreatic cancer.
    El-Rayes BF; Zalupski MM; Shields AF; Ferris AM; Vaishampayan U; Heilbrun LK; Venkatramanamoorthy R; Adsay V; Philip PA
    Invest New Drugs; 2005 Dec; 23(6):583-90. PubMed ID: 16034525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cells.
    Thoennissen NH; Iwanski GB; Doan NB; Okamoto R; Lin P; Abbassi S; Song JH; Yin D; Toh M; Xie WD; Said JW; Koeffler HP
    Cancer Res; 2009 Jul; 69(14):5876-84. PubMed ID: 19605406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibition of cyclooxygenase-2 suppresses the growth of pancreatic cancer cells in vitro and in vivo.
    Xu XF; Xie CG; Wang XP; Liu J; Yu YC; Hu HL; Guo CY
    Tohoku J Exp Med; 2008 Jun; 215(2):149-57. PubMed ID: 18577844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cyclooxygenase inhibitors in combination with taxol on expression of cyclin D1 and Ki-67 in a xenograft model of ovarian carcinoma.
    Li W; Cai JH; Zhang J; Tang YX; Wan L
    Int J Mol Sci; 2012; 13(8):9741-9753. PubMed ID: 22949827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of gemcitabine, irinotecan, and celecoxib in patients with advanced pancreatic cancer.
    Lipton A; Campbell-Baird C; Witters L; Harvey H; Ali S
    J Clin Gastroenterol; 2010 Apr; 44(4):286-8. PubMed ID: 20216081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiangiogenic therapy for human pancreatic carcinoma xenografts in nude mice.
    Jia L; Zhang MH; Yuan SZ; Huang WG
    World J Gastroenterol; 2005 Jan; 11(3):447-50. PubMed ID: 15637766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced effect of gemcitabine by emodin against pancreatic cancer in vivo via cytochrome C-regulated apoptosis.
    Chen H; Wei W; Guo Y; Liu A; Tong H; Wang Z; Tan W; Liu J; Lin S
    Oncol Rep; 2011 May; 25(5):1253-61. PubMed ID: 21305255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of nuclear factor-kappaB on emodin-induced sensitization of pancreatic cancer to gemcitabine].
    Liu A; Hu YS; Wang ZH; Tang LL; Ke PY; Lin SZ
    Yao Xue Xue Bao; 2011 Feb; 46(2):146-52. PubMed ID: 21542284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celecoxib inhibits proliferation and induces apoptosis via cyclooxygenase-2 pathway in human pancreatic carcinoma cells.
    Wu G; Yi J; Di F; Zou S; Li X
    J Huazhong Univ Sci Technolog Med Sci; 2005; 25(1):42-4. PubMed ID: 15934305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.
    Grösch S; Tegeder I; Niederberger E; Bräutigam L; Geisslinger G
    FASEB J; 2001 Dec; 15(14):2742-4. PubMed ID: 11606477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piperlongumine Suppresses Growth and Sensitizes Pancreatic Tumors to Gemcitabine in a Xenograft Mouse Model by Modulating the NF-kappa B Pathway.
    Wang Y; Wu X; Zhou Y; Jiang H; Pan S; Sun B
    Cancer Prev Res (Phila); 2016 Mar; 9(3):234-44. PubMed ID: 26667450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emodin potentiates the antitumor effects of gemcitabine in pancreatic cancer cells via inhibition of nuclear factor-κB.
    Liu A; Chen H; Tong H; Ye S; Qiu M; Wang Z; Tan W; Liu J; Lin S
    Mol Med Rep; 2011; 4(2):221-7. PubMed ID: 21468555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase of cyclooxygenase-2 inhibition with celecoxib combined with 5-FU enhances tumor cell apoptosis and antitumor efficacy in a subcutaneous implantation tumor model of human colon cancer.
    Zhang DQ; Guo Q; Zhu JH; Chen WC
    World J Surg Oncol; 2013 Jan; 11():16. PubMed ID: 23347845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycle effects of nonsteroidal anti-inflammatory drugs and enhanced growth inhibition in combination with gemcitabine in pancreatic carcinoma cells.
    Yip-Schneider MT; Sweeney CJ; Jung SH; Crowell PL; Marshall MS
    J Pharmacol Exp Ther; 2001 Sep; 298(3):976-85. PubMed ID: 11504793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced antitumor efficacy by the combination of emodin and gemcitabine against human pancreatic cancer cells via downregulation of the expression of XIAP in vitro and in vivo.
    Wang ZH; Chen H; Guo HC; Tong HF; Liu JX; Wei WT; Tan W; Ni ZL; Liu HB; Lin SZ
    Int J Oncol; 2011 Nov; 39(5):1123-31. PubMed ID: 21743963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gemcitabine and CHK1 inhibition potentiate EGFR-directed radioimmunotherapy against pancreatic ductal adenocarcinoma.
    Al-Ejeh F; Pajic M; Shi W; Kalimutho M; Miranda M; Nagrial AM; Chou A; Biankin AV; Grimmond SM; ; Brown MP; Khanna KK
    Clin Cancer Res; 2014 Jun; 20(12):3187-97. PubMed ID: 24838526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-I antagonizes the antiproliferative effects of cyclooxygenase-2 inhibitors on BxPC-3 pancreatic cancer cells.
    Levitt RJ; Pollak M
    Cancer Res; 2002 Dec; 62(24):7372-6. PubMed ID: 12499282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.